Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only 48 million shares outstanding
Nice report. Profitable
Thank you! Yes I do think as well that eventually this will trade at much higher prices!
Has this stock ever traded above $1. Just curious. Thank you!
Pretty nice report today
He said he is only one doing something! He actually said that he never sold share! Of course he will say that. No guilty.......
I think he's blaming me and maybe bashers and we never had anything with how company was run down first with management and finished with Brad and co.
I saw that yesterday.
Yes. He took advantage of situation that's for sure.
I have no clue. Never heard of him before all drama happened
Let's see what next quarterly report brings! I do like admt and I'm adding to my position.
News from ADM Tronics…
ADM Tronics Launches Aurex International Subsidiary with New Website
Northvale, NJ – June 1, 2017 - ADM Tronics Unlimited, Inc. (OTCQB - ADMT) announced today its subsidiary, Aurex International, Inc. (“AIC”), is taking an innovative, three-pronged approach to launching its entree into the tinnitus marketplace. Tinnitus is a hearing condition commonly known as "ringing in the ears.” The American Tinnitus Association estimates there are up to 50 million tinnitus sufferers in the U.S. and some 250 million worldwide. The U.S. Center for Disease Control estimates that nearly 15% of the general public - over 45 million Americans - experience some form of tinnitus. The U.S. Veterans Health Administration ("VA") reports that tinnitus is the most prevalent combat-related disability affecting veterans, making it a high-priority healthcare issue facing the military and the VA.
At the forefront of AIC’s three-pronged approach is the “Tinnitus Shield™”, an innovative, patent-pending hearing protection device ADMT jointly developed with Gama Research and Development LTD, also known as Otifleks., an award-winning producer of advanced hearing protection devices. Otifleks, a Turkish-based company, specializes in research, development and manufacturing of specialized advanced hearing protection devices which have had distribution in certain countries in Europe, particularly to the military and for multiple other applications. The joint collaboration between ADMT and Otifleks was to develop a product specifically for the unique needs of the tinnitus marketplace.
The second prong of AIC’s “go to market” strategy is to introduce to the North American markets Otifleks’ line of advanced hearing protection products, which include products for individuals who suffer from transient attacks of tinnitus and other otolaryngology problems such as experienced in air travel, certain medical procedures and various noise related occupations.
And lastly, the final prong - on December 13, 2016 ADMT announced that it was re-engineering it's patented, non-invasive medical device used for the treatment and control of tinnitus, called the Aurex-3®, which was previously FDA-cleared. The new version of the device will be enhanced to state-of-the-art digital control, allowing for smartphone, tablet and cloud integration, expected to significantly improve patient usability and compliance. Additionally, the new Aurex-3® will include the ability to wirelessly monitor and forward patient progress directly to their physician.
“Our efforts in developing the Tinnitus Shield with Otifleks will be our launching point for AIC, which we believe will help maintain our record of 14 consecutive quarters of increased revenues,” stated Andre’ DiMino, President and CEO of ADMT.
In summary, AIC is assembling a technological product suite of hearing devices that has the potential to prevent, reduce and treat tinnitus. AIC anticipates rolling out its first product, the “Tinnitus Shield™” in the next 60 days. In preparation AIC has developed its new website. Visit www.aurex3.com.
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Medical Device Design, Engineering, Regulatory and Manufacturing Services; Proprietary Electronic Medical Devices; and Eco-Friendly, Water-Based Formulations. ADMT’s multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company’s websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are “forward looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.
Contact: Andre’ DiMino, 201-767-6040, andre@admtronics.com
Copyright © 2017 ADM Tronics Unlimited, Inc., All rights reserved.
You are receiving this email because you responded to our postcard mailing and requested to be on our list. We will never share this list with any other company.
Our mailing address is:
ADM Tronics Unlimited, Inc.
224S Pegasus AvenueNorthvale, NJ 07647
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list
Email Marketing Powered by MailChimp
Most of my money is going different direction
True! Thx for clarifying that. I wish it never happened.
Yes I decided not to pay for fees anymore
It doesn't
I did and it's same old story.
What can we do man? So many scams and unfortunately looks like he run one!
Just give up man. I lost a lot and I moved on. Took tax loss.
We can only hope company will eventually start doing something with investment community!
Looks everyone is waiting for next report!
500 shares sale to make stock in red day.
Can't wait to see results this year.
Thx. To you as well!
ADMT CEO Andre' DiMino added, "We are investing in our future by adding leading-edge equipment and by ramping up our research, development and engineering activities specifically for ADMT's suite of proprietary products. The expenses related to this investment in our future resulted in a loss from operations for the December 31, 2016 quarter. However, realizing these expenses in the 3rd quarter bodes well for the Company's growth in our 4th quarter of this year, and for years thereafter." Mr. DiMino concluded, "Furthermore, I am particularly pleased that our income from operations for the first three quarters of this year is up 180%, which is almost triple the income from operations from the first three quarters of last year. We continue to deliver on all of our goals, and we are determined to bring ADM Tronics to the forefront of the electronic medical device industry."
http://www.prnewswire.com/news-releases/adm-tronics-reports-third-quarter-of-fiscal-year-2017-results-300410934.html
Well of course everything is possible with stock that we trade!
It was election time! Ordering Elias down!
But this is quote from one of news!
"Fortunately, we are seeing an increase in requests and order flow since November 8, 2016, when a more med tech friendly administration was elected."
I'll take cheap ones and wait!
Added little more on this selloff
Not much but first loss in while.
It's out
What's your target? You are here since I got this stock several years ago.
In November CEO commented "As we previously reported, certain analysts have begun to take notice of our improved financial performance and position and have advised us that a company, such as ours, should expect a share price of between 18 to 25 times income. If our income trend continues, and their multiple advice is accurate, that could translate into a share price ranging from $0.50 to $0.70 per share."
http://www.prnewswire.com/news-releases/adm-tronics-ceo-comments-on-record-financial-results-300366531.html
Added little more today as well.